Roche
NEWS
The company says it plans to file an IND for the candidate, dubbed CFT8919, by the middle of next year.
The clinical trial, which will be conducted by Xilio, will assess XTX101’s safety and efficacy as a monotherapy, as well as in combination with Keytruda, in solid tumors.
Please check out the biopharma industry’s COVID-19 stories that are trending for May 18, 2021.
Biotechnology firm Ginkgo Bioworks is going public via a merger with Soaring Eagle Acquisition Corp.
BioSpace takes an in-depth look at the Top 25 of Q1. You should be aware of these biopharma companies as they hold a great future ahead. So, check them out.
Please check out the biopharma industry’s COVID-19 stories that are trending for April 27, 2021.
The fate of three cancer immunotherapies that had been authorized under the U.S. Food and Drug Administration’s Accelerated Approval pathway will be determined next week following failures in confirmatory trials.
Executives at pharmaceutical companies are known for receiving large salaries. When bonuses and stock options are factored into the picture, their annual compensation can jump into the range of tens of millions of dollars, like Pfizer’s Albert Bourla, Alex Gorsky from Johnson & Johnson, and AstraZeneca’s Pascal Soriot.
The Swiss pharma giant quietly announced the cuts this morning in a breakdown of its first quarterly financial report.
JOBS
IN THE PRESS